vaccine - The African Mirror

Jul

2020

COVID-19 vaccine developer cautious on 2020 roll-out

ALISTAIR SMOUT THE University of Oxford's possible COVID-19 vaccine could be rolled out by the end of the year but there is no certainty, the lead developer of the vaccine has announced. The experimental vaccine, which has been licensed to AstraZeneca, produced an immune response in early-stage clinical trials, data showed on Monday, preserving hopes it could be in use by the end of 2020. "The end of the year target for getting vaccine roll-out, it's a possibility but there's absolutely no certainty about that because we need three things to happen," Sarah Gilbert told BBC Radio. She said it…

Jul

2020

By The African Mirror

Over a million doses of Oxford/AstraZeneca COVID-19 vaccine possible by September – researcher

NEWS

EARLY estimates of the production of a million doses of the University of Oxford's experimental COVID-19 vaccine by September could be an underestimate depending on how quickly late-stage trials can be completed, a researcher has said. "There might be a million doses manufactured by September: that now seems like a remarkable underestimate, given the scale of what's going on," Adrian Hill of the University of Oxford said, referring to the manufacturing capability of partner AstraZeneca. "Certainly there'll be a million doses around in September. What's less predictable than the manufacturing scale-up is the incidence of disease, so when there'll be…

Jul

2020

By The African Mirror

First human trial of AstraZeneca COVID-19 vaccine shows promise

COVID-19

ASTRAZENECA's experimental COVID-19 vaccine was safe and produced an immune response in early-stage clinical trials in healthy volunteers, data has shown, with the strongest response seen in people who received two doses. The vaccine, called AZD1222 and being developed by AstraZeneca and scientists at Britain's University of Oxford, did not prompt any serious side effects and elicited antibody and T-cell immune responses, according to trial results published in The Lancet medical journal. "There is still much work to be done before we can confirm if our vaccine will help manage the COVID-19 pandemic, but these early results hold promise," vaccine…

Jul

2020

By The African Mirror

Russia expects to make COVID-19 vaccine being developed in Britain

WORLD

RUSSIA expects a deal with AstraZeneca for it to manufacture a COVID-19 vaccine being developed by the pharmaceuticals giant and Oxford University to go ahead despite allegations it has been trying to steal vaccine data, its wealth fund head said. Britain's National Cyber Security Centre said on Thursday that hackers backed by the Russian state were trying to steal COVID-19 vaccine and treatment research from academic and pharmaceutical institutions around the world, allegations the Kremlin denied. Kirill Dmitriev, head of the Russian Direct Investment Fund, said in an interview on Friday that the allegations were false and that Moscow did…